Contact Us

MEETING NEWS

Harbin Asian Winter Games creates beautiful and unforgettable memories of ice and snow

Feb 14, 2025

BEIJING,Feb. 13,2025-- A report from People\'s Daily: The ongoing 9th Asian Winter Games held in Harbin,northeast China\'s Heilongjiang province,themed "Dream of Winter,Love Among Asia," emb

ShengShu Technology Lays Foundation for Scalable AI Video Generation with Launch of Vidu API Offering Instant Access and Industry-leading Speed for Enterprises & Developers

Feb 14, 2025

SINGAPORE,Feb. 13,2025-- ShengShu Technology,a world pioneer in generative AI video,announces the API platform for its flagship video generation application,Vidu,marking a major advancement in scalabl

Regal Hotels Leverages Network to Support Hong Kong's Healthcare Professionals with an Exclusive Long-stay Accommodation Programme

Feb 14, 2025

HONG KONG,Feb. 13,2025-- Regal Hotels International is leveraging its extensive hotel network to launch the exclusive "Long-stay Accommodation Programme" for Hospital Authority (HA) staff.

Namibox, Tencent, and Sichuan Education Press Forge Strategic Partnership to Develop Innovative AI-Powered Learning Solutions

Feb 14, 2025

SHANGHAI,Feb. 13,2025-- Jinxin Technology Holding Company (the "Company") (Nasdaq: NAMI),an innovative provider of digital-content products and services in China,today announced an in-depth

Akeso Announces IND Acceptance for AK139, a Bispecific Antibody Targeting IL-4Rα and ST2 for Respiratory and Skin Diseases

Feb 14, 2025

HONG KONG,Feb. 14,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China Natio

Accropeutics Announces First Patient Dosed in Phase Ib Study of RIPK2 Inhibitor AC-101

Feb 14, 2025

NEW YORK,Feb. 13,2025-- Accropeutics Inc. (Accropeutics),a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms of regulated cell deat

1 ... 98 99 100 101 102 103 104 ... 364